Kidney Nurses to Congress: Systemic Failures Demand Urgent Policy Action

WASHINGTON, D.C. – June 01, 2026 – In a move that brings frontline medical expertise directly to the nation's capital, the American Nephrology Nurses Association (ANNA) is dispatching its members to Capitol Hill for a high-stakes advocacy mission. The 2026 Advocacy Forum, scheduled for June 8-9, will see nephrology nurses—the specialized caregivers for millions of Americans with kidney disease—trade their scrubs for business attire to meet directly with lawmakers. Their message is stark: the nation's kidney care system is strained by a dual crisis of a collapsing workforce and mounting barriers to patient care, and only decisive federal action can avert a worsening public health catastrophe.

"Nephrology nurses see firsthand how federal policy decisions impact patient care, workforce sustainability, and access to lifesaving treatment," said Michelle Gilliland, ANNA National President for 2026-2027, in a statement announcing the forum. "The Advocacy Forum empowers our nurses to bring their frontline expertise to Capitol Hill and advocate for policies that strengthen the nursing workforce, advance kidney research, and improve outcomes for the millions of people living with kidney disease."

Beyond the Bedside: A Workforce on the Brink

The urgency of ANNA's mission is underscored by a severe and deepening crisis within the nephrology nursing workforce. The nurses heading to Washington are not just advocating for their patients; they are fighting for the very survival of their profession. Recent data paints a grim picture: the nephrology nursing workforce is rapidly aging, with a 2022 ANNA survey revealing that over 53% of its nurses are between 50 and 65 years old, and nearly 14% are over 65. This demographic cliff signals a looming mass retirement that the current pipeline of new nurses is ill-equipped to backfill.

Compounding the issue are staggering rates of burnout and turnover. Since 2004, outpatient dialysis facilities have reported an annual deficit of 5-7% in registered nurse positions. The immense pressure of a high-acuity patient population, coupled with systemic staffing shortages, has created an environment where even new nurses are driven away. This reality is at the heart of ANNA's push for the reauthorization of the Title VIII Nursing Workforce Reauthorization Act and robust Fiscal Year 2027 funding for its associated programs.

These programs, administered by the Health Resources and Services Administration (HRSA), are a critical lifeline for bolstering the nursing pipeline. They provide funding for education, traineeships, and faculty development, with a focus on increasing the number of nurses in underserved communities. For nephrology, this funding is essential for developing the specialized skills required to manage complex kidney disease and for attracting a new generation of caregivers to a field in desperate need.

Confronting Barriers to Patient Care

While the workforce crisis looms in the background, the immediate, daily reality for patients is one of mounting obstacles to care. ANNA's legislative agenda directly targets the systemic barriers that prevent patients from receiving timely, affordable, and high-quality treatment. A key focus is the Living Donor Protection Act, a bill designed to remove significant disincentives for individuals willing to become living organ donors.

Currently, many potential donors fear losing their jobs or facing discrimination from life and disability insurance providers. This legislation seeks to provide job protection under the Family and Medical Leave Act (FMLA) and prohibit such insurance discrimination, thereby expanding the pool of available organs and offering a lifeline to thousands on transplant waiting lists. With significant geographical and racial disparities already plaguing transplant access—patients in the Southeast, for example, have disproportionately lower access—removing these barriers is a critical step toward equity.

The financial toxicity of kidney disease is another formidable barrier. Medicare spending for a single hemodialysis patient averaged over $93,000 in 2019, and out-of-pocket costs can be ruinous. This financial strain is exacerbated by racial disparities; Black Americans are nearly four times more likely than White Americans to experience kidney failure and represent over 35% of all dialysis patients. ANNA's advocacy for policies under the umbrella of a "Kidney Care Access Protection Act" aims to ensure that insurance coverage is comprehensive and that cost is not the deciding factor in a patient's ability to access life-sustaining care.

A Push for a New Era of Kidney Research

For decades, the primary treatments for end-stage kidney disease have remained dialysis and transplantation—innovations from the mid-20th century. Advocates argue that a chronic lack of federal investment has stifled the development of new therapies. To address this, ANNA nurses will be urging Congress to approve significant funding increases for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of Nursing Research (NINR).

NIDDK is the primary engine for federal research into kidney disease, and increased allocations could accelerate breakthroughs in prevention, diagnosis, and treatment. Similarly, funding for NINR supports the science behind nursing practice itself, leading to evidence-based improvements in patient management and quality of life for those living with chronic illness. By advocating for research, the nurses are investing in a future where their patients have more and better options.

The Strategy: From Frontline Expertise to Federal Policy

The ANNA Advocacy Forum represents a sophisticated model of grassroots lobbying. In partnership with Soapbox Consulting, a government relations firm, the association is ensuring its members are fully prepared to make a compelling case. Participants receive focused training on the legislative process and the specific bills they are supporting before being dispatched to personalized meetings with members of Congress and their staff.

This strategy leverages the most powerful tool these nurses possess: their personal experience. Lawmakers will hear directly from the individuals who manage dialysis treatments, comfort worried families, and witness the daily struggles of patients navigating a complex and often unforgiving healthcare system. Their stories provide a human context to policy debates, transforming abstract budget lines and legislative text into tangible impacts on constituents' lives. By bringing the realities of the clinic to the corridors of power, ANNA's nurses hope to catalyze the political will necessary to mend a system that is failing both its caregivers and the vulnerable patients they serve.